Literature DB >> 24975762

Evidence-based management of developmental dysplasia of the hip.

Anthony Philip Cooper1, Siddesh Nandi Doddabasappa1, Kishore Mulpuri2.   

Abstract

Developmental Dysplasia of the Hip (DDH) refers to a spectrum of abnormalities involving the developing hip. These abnormalities range from mild instability to frank dislocation of the joint. It is important to treat the condition effectively in order to encourage the hip to develop normally and produce good long-term results. This article reviews the evidence related to the treatment of DDH. The quality of evidence for DDH management remains low, with little uniformity in terminology and most studies being retrospective in nature. Given this, it is not possible to recommend or reject most treatment modalities based on existing studies.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Developmental dysplasia hip (DDH); Evidence; Management; Treatment

Mesh:

Year:  2014        PMID: 24975762     DOI: 10.1016/j.ocl.2014.03.005

Source DB:  PubMed          Journal:  Orthop Clin North Am        ISSN: 0030-5898            Impact factor:   2.472


  21 in total

Review 1.  Managing Developmental Dysplasia of the Hip.

Authors:  James Tomlinson; Dominic O'Dowd; James Alfred Fernandes
Journal:  Indian J Pediatr       Date:  2016-05-31       Impact factor: 1.967

2.  [Pavlik harness for the treatment of congenital hip dysplasia types D III and IV].

Authors:  D Zajonz; S Strobel; M Wojan; N von der Höh; P Brandmaier; C Josten; E Schumann; C-E Heyde
Journal:  Orthopade       Date:  2016-01       Impact factor: 1.087

3.  Radiographic outcome of children older than twenty-four months with developmental dysplasia of the hip treated by closed reduction and spica cast immobilization in human position: a review of fifty-one hips.

Authors:  YiQiang Li; YueMing Guo; XianTao Shen; Hang Liu; HaiBo Mei; HongWen Xu; Federico Canavese
Journal:  Int Orthop       Date:  2019-04-12       Impact factor: 3.075

4.  Does Perfusion MRI After Closed Reduction of Developmental Dysplasia of the Hip Reduce the Incidence of Avascular Necrosis?

Authors:  Alex L Gornitzky; Andrew G Georgiadis; Mark A Seeley; B David Horn; Wudbhav N Sankar
Journal:  Clin Orthop Relat Res       Date:  2016-05       Impact factor: 4.176

5.  Teardrop and sourcil line (TSL): a novel radiographic sign that predicts residual acetabular dysplasia (RAD) in DDH after closed reduction.

Authors:  Peng Huang; Dahui Wang; Yueqiang Mo; Yiming Zheng; Bo Ning
Journal:  Transl Pediatr       Date:  2022-04

Review 6.  Splinting for the non-operative management of developmental dysplasia of the hip (DDH) in children under six months of age.

Authors:  Kerry Dwan; Jamie Kirkham; Robin W Paton; Emma Morley; Ashley William Newton; Daniel C Perry
Journal:  Cochrane Database Syst Rev       Date:  2022-10-10

7.  Retrospective Comparison of Outcomes Between Closed and Open Reduction for Developmental Dysplasia of the Hip in Children Aged 6-24 Months.

Authors:  Shuyu Ma; Weizheng Zhou; Lianyong Li; Enbo Wang; Lijun Zhang; Qiwei Li
Journal:  Indian J Orthop       Date:  2022-07-05       Impact factor: 1.033

8.  Closed reduction and dynamic cast immobilization in patients with developmental dysplasia of the hip between 6 and 24 months of age.

Authors:  YiQiang Li; QingHe Zhou; Yuanzhong Liu; WeiDong Chen; JingChun Li; Federico Canavese; HongWen Xu
Journal:  Eur J Orthop Surg Traumatol       Date:  2018-08-03

9.  Relapsed hip stiffness after recovery of range of motion in a hip treated for developmental dysplasia of the hip? Think again: A case report.

Authors:  Hasan Alanazi; Faisal Almalik; Naif Alanazi; Thamer Alhussainan
Journal:  Int J Surg Case Rep       Date:  2020-11-30

10.  Risk factors for failed closed reduction in dislocated developmental dysplastic hips.

Authors:  Sebastian Gottfried Walter; Christoph Hans-Jürgen Endler; Anna Christina Remig; Julian A Luetkens; Rahel Bornemann; Richard Placzek
Journal:  Int Orthop       Date:  2020-06-01       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.